Eugenyl benzoate

• Description :

  Eugenyl benzoate has the potency for scavenging of DPPH radical. Eugenyl Benzoate Derivatives can be used for development of BCL-2 inhibitors[1][2].

• UNSPSC :

  12352005

• Hazard Statement :

  H317

• Target :

  Others

• Type :

  Natural Products

• Related Pathways :

  Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/eugenyl-benzoate.html

• Purity :

  90.0

• Solubility :

  10 mM in DMSO

• Smiles :

  C=CCC1=CC=C(OC(C2=CC=CC=C2)=O)C(OC)=C1

• Molecular Formula :

  C17H16O3

• Molecular Weight :

  268.31

• Precautions :

  H317

• References & Citations :

  [1]Jabbari A, et al. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors. Bioorg Med Chem. 2012 Sep 15;20 (18) :5518-26.|[2]Fadilah, et al. Synthesis and in vitro Activity of Eugenyl Benzoate Derivatives as BCL-2 Inhibitor in Colorectal Cancer with QSAR and Molecular Docking Approach. doi: https://doi.org/10.1101/2020.08.17.253591

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [531-26-0]